Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.145 SEK | -4.61% | +2.22% | -19.08% |
Mar. 20 | Sweden's SynAct Pharma Names New CEO | MT |
Mar. 20 | SynAct Pharma AB Elects New Board Members and Chairman at Extraordinary General Meeting | CI |
Sales 2022 | - | Sales 2023 | - | Capitalization | 314M 3.4B |
---|---|---|---|---|---|
Net income 2022 | -99M -1.07B | Net income 2023 | -216M -2.33B | EV / Sales 2022 | - |
Net cash position 2022 | 106M 1.15B | Net cash position 2023 | 61.76M 668M | EV / Sales 2023 | - |
P/E ratio 2022 |
-22.7
x | P/E ratio 2023 |
-1.33
x | Employees | 5 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 70.83% |
1 day | -4.61% | ||
1 week | +2.22% | ||
Current month | -17.30% | ||
1 month | +4.31% | ||
3 months | +0.07% | ||
6 months | -57.22% | ||
Current year | -19.08% |
Managers | Title | Age | Since |
---|---|---|---|
Björn Westberg
DFI | Director of Finance/CFO | 62 | 23-05-31 |
Kirsten Harting
CTO | Chief Tech/Sci/R&D Officer | - | Feb. 14 |
Thomas Boesen
COO | Chief Operating Officer | - | 21-01-25 |
Members of the board | Title | Age | Since |
---|---|---|---|
Thomas Jonassen
CTO | Chief Tech/Sci/R&D Officer | - | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-23 | 7.145 | -4.61% | 178 614 |
24-04-22 | 7.49 | +10.72% | 217,213 |
24-04-19 | 6.765 | +0.89% | 58,519 |
24-04-18 | 6.705 | -1.61% | 47,333 |
24-04-17 | 6.815 | -2.50% | 147,189 |
Delayed Quote Nasdaq Stockholm, April 23, 2024 at 11:29 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-19.08% | 24.41M | |
+3.43% | 42.11B | |
+48.83% | 40.08B | |
+8.66% | 40B | |
-10.82% | 26.87B | |
+8.14% | 24.58B | |
-23.72% | 18.44B | |
+2.03% | 11.94B | |
+33.68% | 11.66B | |
+7.44% | 11.01B |
- Stock Market
- Equities
- SYNACT Stock